Larvol Delta - ViralClear-Publishes-in-F1000-Research-In-Vitro-Data-Demonstrating-Synergy-between-Merimepodib-and-Remdesivir-Against-SARSCoV2-the-Cause-of-COVID19

remdesivir - Generic mfg.

Vicromax (merimepodib) - BioSig Tech

http://www.globenewswire.com/news-release/2020/05/14/2033488/0/en/ViralClear-Publishes-in-F1000-Research-In-Vitro-Data-Demonstrating-Synergy-between-Merimepodib-and-Remdesivir-Against-SARS-CoV-2-the-Cause-of-COVID-19.html

May 14, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next